Fadi El-Eter

I run a major site in project management - and so I read a lot about the topic. In the past few days - I've been reading quite a few posts on the healthcare.gov website, and what happened. What I noticed that everyone all of a sudden seemed to be a...

2 days ago I have written about BIOS, and how it was at a bargain price, yesterday the stock almost touched $4 (apparently there is strong support at this level), and today, the stock reversed the downward trend on 2 times the average volume and it went...

One of the stocks that I really love is BIOS, and with a P/E that is less than 5, what's not to love. BIOS is the ticker for BioScrip Inc., a pharmaceutical company that is actually making money, unlike (most of) the rest in this industry. The...

Sanofi is after Genzyme for a few months now, with no avail. Genzyme just won't sell. Sanofi today began a hostile takeover to buy Genzyme. The hostile takeover values the company at $18.5 billion, or $69 per share, the same price that Sanofi offered to...

I was having another pass at the top losing stocks of Friday, and I found these: CLDX (Celldex): A pharmaceutical company that reported a net loss of 30 cents per share on Friday morning. The stock dropped 26.15% on 20 times average volume. The stock...